Anthonius de Boer
Biographic Data
| ID | 7069603 |
|---|---|
| NAME | Anthonius de Boer |
| GIVEN NAMES | Anthonius |
| FAMILY NAME | de Boer |
| SIGNATURE | DE BOER A |
| AFFILIATIONS | Utrecht University |
| ORCID | 0000-0002-9485-8037 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2008 |
| LATEST PUBLICATION YEAR | 2017 |
| H-INDEX | 0 |
The impact of quality-of-life data in relative effectiveness assessments of new anti-cancer drugs in European countries
Whilst national guidelines recognize the relevance of QoL to determine the relative effectiveness of new anti-cancer drugs, this is not well-reflected in current assessments. Developing and implementing into REAs specific evidence requirements for QoL data would improve the use of this patient-centred outcome in future reimbursement and pricing decisions
Comparison of knowledge and accessibility to information sources of HIV/Aids between blind and sighted populations in Nigeria
The aim of this study was to compare the HIV/AIDS knowledge and accessibility to HIV/AIDS information between blind and sighted individuals in Nigeria. A cross-sectional survey was undertaken among rural and urban blind (57) and sighted (62) adolescents in 2006. A structured questionnaire was used to collect data about HIV/AIDS symptoms, transmission and prevention knowledge, as well as accessibility to sources of HIV/AIDS information. Binary log…
No prominent works on this page.
Comparison of knowledge and accessibility to information sources of HIV/Aids between blind and sighted populations in Nigeria
The aim of this study was to compare the HIV/AIDS knowledge and accessibility to HIV/AIDS information between blind and sighted individuals in Nigeria. A cross-sectional survey was undertaken among rural and urban blind (57) and sighted (62) adolescents in 2006. A structured questionnaire was used to collect data about HIV/AIDS symptoms, transmission and prevention knowledge, as well as accessibility to sources of HIV/AIDS information. Binary log…
The impact of quality-of-life data in relative effectiveness assessments of new anti-cancer drugs in European countries
Whilst national guidelines recognize the relevance of QoL to determine the relative effectiveness of new anti-cancer drugs, this is not well-reflected in current assessments. Developing and implementing into REAs specific evidence requirements for QoL data would improve the use of this patient-centred outcome in future reimbursement and pricing decisions
Environmental health (2 works) · Medicine (2 works) · Adolescent Sexual and Reproductive Health (1 work) · Blindness (1 work) · Cancer (1 work) · Cancer drugs (1 work) · Computer Science (1 work) · Cost effectiveness (1 work) · Cross-sectional study (1 work) · Economic and Financial Impacts of Cancer (1 work)